Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Warrants Outstanding (Details)

v3.21.1
Shareholders' Deficit - Schedule of Warrants Outstanding (Details) - Warrant [Member]
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Shares Outstanding, Beginning Balance | shares 39,295
Shares, Granted | shares
Shares, Cancelled | shares (8,770)
Shares, Exercised | shares
Shares Outstanding, Ending Balance | shares 30,525
Shares Exercisable, Ending Balance | shares 30,525
Weighted-Average Exercise Price, Outstanding Beginning Balance | $ / shares $ 200.72
Weighted-Average Exercise Price, Granted | $ / shares
Weighted average Exercise price, Cancelled | $ / shares 510.04
Weighted-Average Exercise Price, Exercised | $ / shares
Weighted-Average Exercise Price, Outstanding Ending Balance | $ / shares 111.86
Weighted-Average Exercise Price, Exercisable Ending Balance | $ / shares $ 111.86
Weighted Average Remaining Contractual Term (years), Outstanding Beginning 11 months 4 days
Weighted Average Remaining Contractual Term (years), Outstanding Ending 10 months 25 days
Weighted Average Remaining Contractual Term (years), Exercisable Ending 10 months 25 days